Navigation Links
Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop
Date:9/25/2008

of complement in myocardial ischemia/reperfusion injury and antibody-mediated rejection in a mouse heterotopic heart transplant model

Carl Atkinson*, Yongquan Gong, Yuxiang Huang, Emily Pauling, Martin Goddard, Stephen Tomlinson

Oct. 1, 2008, Posters - 10:30 a.m. - noon, Session 2, Poster 196

Oral Presentation:

mAb171

Treatment with a highly inhibitory monoclonal antibody directed to the C3d ligand binding site on human CR2/CD21 suppresses antigen-specific immune responses in vivo

Liudmila Kulik*, Jonathan P. Hannan, Brigitte T. Huber, V. Michael Holers

Oct. 1, 2008, Animal models (Room: Montreal), 9:30 a.m. - 9:45 a.m., Oral 49

About Taligen Therapeutics

Taligen Therapeutics is focused on the discovery and development of novel protein therapeutics that are designed to modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases. The company's lead therapeutic candidates are monoclonal antibodies and recombinant fusion proteins that target key factors in the alternative pathway, which Taligen's founders have validated as an important amplification loop in the inflammation process. Taligen's headquarters and late-stage research and development operations are located in Cambridge, Mass. The company also maintains a drug discovery operation in Denver under Taligen's chief scientific officer Michael Holers, M.D., which closely collaborates with an international complement biology research community. For more information, visit http://www.taligentherapeutics.com.

This press release contains forward-looking statements that involve risks and uncertainties, including statements relating to development of the Company's product candidates and potential advantages of the Company's technology and product candidates. Actual results could differ materially from those projected and the Compan
'/>"/>

SOURCE Taligen Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Baxter Initiates Phase III Trial for the Treatment of Alzheimers Disease
2. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
3. Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
4. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
5. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
6. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimers Disease
7. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
8. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
9. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
10. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
11. SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  Alere Inc. (NYSE: ... issued the following statement today in support of President ... "As the global leader in rapid diagnostics ... a national strategy to address the serious threat of ... with the Administration on initiatives to promote the development ...
(Date:9/19/2014)... , Sept. 19, 2014  Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, announced today that it has ... shares of common stock and 3,605,042 unregistered warrants ... price for one registered share of common stock ... share of common stock will be $3.475.  The ...
(Date:9/19/2014)... and ORLANDO, Fla. , Sept. 19, ... therapy continues to grow, with the publication of two ... in Otolaryngology – Head and Neck Surgery ... worsening of both objective and subjective measures of sleep ... Inspire therapy for the reduction in obstructive sleep apnea ...
Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... ALEXANDRIA, Va., March 1, 2012  The National Community ... campaign launched today by the Pharmaceutical Care Management ... (PBMs). (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... said NCPA Senior Vice President for Government Affairs John ...
... PARSIPPANY, N.J., March 1, 2012  PDI, Inc. (Nasdaq: ... its fourth quarter and full year 2011 financial results ... and host a conference call on Thursday, March 8, ... information: ,  Date:Thursday, March 8, 2012Time:8:30 am Eastern timeDial-in ...
Cached Medicine Technology:NCPA Blasts Irresponsible Ad by PBM Lobby as an Affront to Fighting Drug Diversion, Pharmacy Crime 2NCPA Blasts Irresponsible Ad by PBM Lobby as an Affront to Fighting Drug Diversion, Pharmacy Crime 3
(Date:9/22/2014)... The Ruby Report was launched by the publisher ... in Louisville, Kentucky. This release followed the May 6, ... attended by 60 people from the local area. ... while conducting her research, what drove her to study ... what she believes companies can do to be successful ...
(Date:9/21/2014)... birth the birth of an infant prior to ... problem that has increased over the past two decades. ... Prevention (CDC), preterm birth affects nearly 500,000 babies each ... U.S. While medical care has improved survival rates for ... the neurodevelopmental outcomes of preterm infants. , Research led ...
(Date:9/21/2014)... 21, 2014 Hastings and Hastings, a ... record demand for aggressively discounted accident victim attorney’s fees. ... the Valley each year, it is more important than ... discounted attorney’s fees as a way to enjoy more ... has been a frontrunner when it comes to delivering ...
(Date:9/21/2014)... 21, 2014 Burnaby Physiotherapists at Absolute ... clients in order to help them with preventative care. ... the clinic that will help clients understand their problem ... take active participation in the healing process. With higher ... will be able to facilitate the therapy that is ...
(Date:9/21/2014)... "I wanted to be able to obtain a ... energy drinks," said an inventor from Fresh Meadows, N.Y. ... plain, old coffee. That is why I came up ... CHEWING GUM to provide a healthy energy boost that ... nutritious vitamins, minerals and antioxidants. It also features a ...
Breaking Medicine News(10 mins):Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 2Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 3Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 3Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2
... have developed the first genetically altered monkey model that ... according to a new study funded by the National ... understand this complex, devastating and incurable genetic disorder affecting ... advance of online publication edition of Nature, could lead ...
... could offer therapy option for cancer patients ... medical techniques, it may be possible to create replacement ... to cancer. , That,s the conclusion of U.S. researchers ... Replacement bladders made from intestinal tissue have proven successful ...
... Men who come to the hospital with pneumonia generally are ... over the next year, despite aggressive medical care, according to ... International Conference of the American Thoracic Society. Scientific sessions are ... well known that women live longer than men. We have ...
... post-traumatic stress disorder (PTSD) among caregivers of deceased ... than in the average population, according to researchers ... well as their perceptions of the transplant recipients ... presented at the American Thoracic Societys 2008 International ...
... Study finds mortality and survival rates equal for both ... Minimally-invasive laparoscopic surgery and open surgery for colon cancer ... from 12 international studies involving over 3,300 patients. ... afraid that laparoscopy might impair survival in colorectal cancer ...
... aftermath of central China,s,earthquake, up to 50,000 people ... 150,000 were injured. An estimated 10 million people ... their homes. With great sorrow for,these widespread losses ... US$30,000, for a total of US$50,000. With contributions ...
Cached Medicine News:Health News:Researchers develop first transgenic monkey model of Huntington's disease 2Health News:Replacement Bladder Grown From Body's Own Cells 2Health News:Men at increased risk of death from pneumonia compared to women 2Health News:Depression and PTSD symptoms in caregivers of lung transplant patients 2Health News:Outcomes Similar for Laparoscopic, Open Colon Cancer Surgeries 2Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2
... Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope provides a new ... The latest in Fujinon engineering combines ... guide, and a wide 90 degree field ... distal tip diameter. In addition, the ...
... Tip Laryngoscopes are the most ... The articulating tip aids during ... improved view of epiglottis. Available ... styles. We guarantee your complete ...
German Style MacIntosh Fiber Optic Blade Laryngoscopes...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: